Sclerotium rolfsii lectin induces stronger inhibition of proliferation in human breast cancer cells than normal human mammary epithelial cells by induction of cell apoptosis

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Savanur, Mohammed Azharuddin ^a,b   Eligar, Sachin M ^a,b   Pujari, Radha ^e   Chen, Chen ^b   Mahajan, Pravin ^d   Borges, Anita ^d   Shastry, Padma ^e   Ingle, Arvind ^c   Kalraiya, Rajiv D ^c   Swamy, Bale M ^a,b   Rhodes, Jonathan M ^b   Yu, Lu Gang ^b   Inamdar, Shashikala R ^a,b  

^a KARNATAK UNIVERSITY   (India)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c ADVANCED CENTRE FOR TREATMENT RESEARCH AND EDUCATION IN CANCER   (India)

^d SL Raheja Hospital   (India)

^e NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; GLYCAN; LECTIN; SCLEROTIUM ROLFSII LECTIN; UNCLASSIFIED DRUG; PROTEIN BINDING;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ATHELIA ROLFSII; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER INHIBITION; CANCER TISSUE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPITHELIUM CELL; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LECTIN BINDING; BASIDIOMYCETES; BREAST TUMOR; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; FEMALE; MAMMARY GLAND; METABOLISM; TUMOR CELL LINE;

ATHELIA ROLFSII;

APOPTOSIS; BASIDIOMYCOTA; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; HUMANS; LECTINS; MAMMARY GLANDS, HUMAN; PROTEIN BINDING;

EID: 84909951960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110107     Document Type: Article

References (27)

1. Van Damme EJ, Lannoo N, Peumans WJ (2008) Plant lectins. Adv Bot Res. 48: 107-209.
2. Mody R, Joshi S, Chaney W (1995) Use of lectins as diagnostic and therapeutic tools for cancer. J PharmacolToxicol Methods. 33: 1-10.
3. Hanisch FGBS (1997) The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinomaassociated antigen. Histol Histopathol. 12: 263-281.
4. Yu LG (2007) The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression. Glycoconj J. 24: 411-420.
5. Springer GF (1984) T and Tn, general carcinoma autoantigens. Science. 224 (4654):1198-206.
6. Samraj AN, Läubli H, Varki N, Varki A (2014) Involvement of a non-human sialic acid in human cancer. Frontiers in oncology, 4: 33
7. Cruijsen HV, Ruiz MG, Valk P, Gruijl TD, Giaccone G (2009) Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. BMC Cancer, 9: 180.
8. Heimburg-Molinaro J, Almogren A, Morey S, Glinskii OV, Roy R, et al. (2009) Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen. Neoplasia. 11: 780-792.
9. Swamy BM, Bhat AG, Hegde GV, Naik RS, Kulkarni S, et al. (2004) Immunolocalization and functional role of Sclerotiumrolfsii lectin in development of fungus by interaction with its endogenous receptor. Glycobiology. 11: 951-957.
10. Chachadi VB, Inamdar SR, Yu LG, Rhodes JM, Swamy BM (2011) Exquisite binding specificity of Sclerotiumrolfsii lectin toward TF-related O-linked mucintype glycans. Glycoconj J. 28: 2849-2856.
11. Leonidas DD, Swamy BM, Hatzopoulos GN, Gonchigar SJ, Chachadi VB, et al. (2007) Structural basis for the carbohydrate recognition of the Sclerotiumrolfsii lectin. J Mol Biol. 368: 1145-1161.
12. Inamdar SR, Savanur MA, Eligar SM, Chachadi VB, Nagre NN, et al. (2012)The TF-antigen binding lectin from Sclerotiumrolfsii inhibits growth of human colon cancer cells by inducing apoptosis in vitro and suppresses tumor growth in vivo. Glycobiology. 22: 1227-1235.
13. Eligar SM, Pujari R, Swamy BM, Shastry P, Inamdar SR (2012) Sclerotiumrolfsii lectin inhibits proliferation and induces apoptosis in human ovarian cancer cell line PA-1. Cell Prolif. 45: 397-403.
14. Brockhausen I, Yang JM, Burchell J, Whitehouse C, Taylor-Papadimitriou J (1995) Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem 233, 607-17
15. Spiro RG (1960) Studies on fetuin, a glycoprotein of fetal serum. I. Isolation, chemical composition, and physiochemical properties. J. Biol. Chem. 235: 2860-2869.
16. Goldman M (1968) In Fluorescent antibody methods. Academic Press. New York. pp. 101-61.
17. Duk M, Lisowska E, Wu JH, Wn AM (1994) The biotin/avidin-mediated microtiter plate lectin assay with the use of chemically modified glycoprotein ligand. Biochem. 221: 266-272.
18. March SC, Parikh I, Cuatrecasas P (1974) A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Anal Biochem. 60: 149-152.
19. Boland CR, Chen YF, Rinderle SJ, Resau JH, Luk GD, et al. (1991) Use of the lectin from Amaranthuscaudatus as a histochemical probe of proliferating colonic epithelial cells. Cancer Res. 51: 657-665.
20. Wyllie AH (1997) Apoptosis: an overview. Br Med Bull. 53: 451-465.
21. Reed JC (2003) Apoptosis-targeted therapies for cancer. Cancer Cell. 3: 17-22.
22. Ashe PC, Berry MD (2003) Apoptotic signaling cascades. ProgNeuropsychopharmacol, Biol Psychiatry. 27: 199-214.
23. Pop C, Salvesen GS (2009) Human caspases: activation, specificity, and regulation. J BiolChem. 284: 21777-21781.
24. Boatright KM, Salvesen GS (2003) Mechanisms of caspase activation. Curr Opin Cell Biol. 15: 725-731.
25. Green DR, Martin SJ (1995) The killer and the executioner: how apoptosis controls malignancy. Current Opinion in Immunology. 7: 694-703.
26. Gambi N, Tramontano F, Quesada P (2008) Poly (ADPR) polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines. BiochemPharmacol. 75: 2356-2363.
27. Fu L, Zhou CC, Yao S, Yu J, Liu B, et al. (2011) Plant lectins: Targeting programmed cell death pathways as antitumor agents. The International Journal of Biochemistry & Cell Biology. 43: 1442-1449.